Literature DB >> 16916763

Antigen presentation machinery (APM) modulation and soluble HLA molecules in the tumor microenvironment: do they provide tumor cells with escape mechanisms from recognition by cytotoxic T lymphocytes?

Naveen Bangia1, Soldano Ferrone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16916763     DOI： 10.1080/08820130600808246

Source DB:  PubMed          Journal:  Immunol Invest        ISSN： 0882-0139            Impact factor:   3.657


× No keyword cloud information.
  8 in total

1.  Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors.

Authors:  Martin H Pedersen; Brian L Hood; Hans Christian Beck; Thomas P Conrads; Henrik J Ditzel; Rikke Leth-Larsen
Journal:  Oncoimmunology       Date:  2017-03-16       Impact factor: 8.110

2.  Soluble plasma HLA peptidome as a potential source for cancer biomarkers.

Authors:  Michal Bassani-Sternberg; Eilon Barnea; Ilan Beer; Irit Avivi; Tami Katz; Arie Admon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

Review 3.  Combination regimens of radiation therapy and therapeutic cancer vaccines: mechanisms and opportunities.

Authors:  Charlie Garnett-Benson; James W Hodge; Sofia R Gameiro
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

Review 4.  Chemotherapy and tumor immunity: an unexpected collaboration.

Authors:  Leisha A Emens
Journal:  Front Biosci       Date:  2008-01-01

Review 5.  Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.

Authors:  M Campoli; S Ferrone
Journal:  Tissue Antigens       Date:  2008-08-12

6.  Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer.

Authors:  Mathilde Allard; Romain Oger; Virginie Vignard; Jean-Michel Percier; Giulia Fregni; Aurélie Périer; Anne Caignard; Béatrice Charreau; Karine Bernardeau; Amir Khammari; Brigitte Dréno; Nadine Gervois
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

7.  Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells.

Authors:  Cornelia Siebenkäs; Katherine B Chiappinelli; Angela A Guzzetta; Anup Sharma; Jana Jeschke; Rajita Vatapalli; Stephen B Baylin; Nita Ahuja
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240

8.  Attacking malignant cells that survive therapy: Exploiting immunogenic modulation.

Authors:  James W Hodge; Anna Kwilas; Andressa Ardiani; Sofia R Gameiro
Journal:  Oncoimmunology       Date:  2013-11-06       Impact factor: 8.110
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.